Literature DB >> 31930012

Glycosylation of natriuretic peptides in obese heart failure: mechanistic insights.

Vibhu Parcha1, Pankaj Arora1,2.   

Abstract

Entities:  

Year:  2019        PMID： 31930012      PMCID： PMC6944616          DOI： 10.21037/atm.2019.10.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

1.  The precursor to B-type natriuretic peptide is an O-linked glycoprotein.

Authors:  Ute Schellenberger; Jessica O'Rear; Andrew Guzzetta; Rodney A Jue; Andrew A Protter; N Stephen Pollitt
Journal:  Arch Biochem Biophys       Date:  2006-04-19       Impact factor: 4.013

2.  The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.

Authors:  Toshio Nishikimi; Masashi Ikeda; Yosuke Takeda; Toshihiko Ishimitsu; Ikuko Shibasaki; Hirotsugu Fukuda; Hideyuki Kinoshita; Yasuaki Nakagawa; Koichiro Kuwahara; Kazuwa Nakao
Journal:  Heart       Date:  2011-06-30       Impact factor: 5.994

3.  Searching for a BNP standard: Glycosylated proBNP as a common calibrator enables improved comparability of commercial BNP immunoassays.

Authors:  Alexander G Semenov; Natalia N Tamm; Fred S Apple; Karen M Schulz; Sara A Love; Ranka Ler; Evgeniya E Feygina; Alexey G Katrukha
Journal:  Clin Biochem       Date:  2016-11-05       Impact factor: 3.281

4.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  J Am Coll Cardiol       Date:  2017-04-28       Impact factor: 24.094

5.  How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.

Authors:  Lori B Daniels; Paul Clopton; Vikas Bhalla; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Philippe G Steg; Arne Westheim; Cathrine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough; Alan S Maisel
Journal:  Am Heart J       Date:  2006-05       Impact factor: 4.749

Review 6.  Natriuretic peptide metabolism, clearance and degradation.

Authors:  Lincoln R Potter
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

7.  ProBNP That Is Not Glycosylated at Threonine 71 Is Decreased with Obesity in Patients with Heart Failure.

Authors:  Lynley K Lewis; Sara D Raudsepp; Timothy C R Prickett; Timothy G Yandle; Robert N Doughty; Christopher M Frampton; Christopher J Pemberton; A Mark Richards
Journal:  Clin Chem       Date:  2019-05-15       Impact factor: 8.327

8.  Race-based demographic, anthropometric and clinical correlates of N-terminal-pro B-type natriuretic peptide.

Authors:  Nirav Patel; Orlando M Gutiérrez; Garima Arora; George Howard; Virginia J Howard; Suzanne E Judd; Sumanth D Prabhu; Emily B Levitan; Mary Cushman; Pankaj Arora
Journal:  Int J Cardiol       Date:  2019-02-21       Impact factor: 4.164

9.  Angiotensin-neprilysin inhibition versus enalapril in heart failure.

Authors:  John J V McMurray; Milton Packer; Akshay S Desai; Jianjian Gong; Martin P Lefkowitz; Adel R Rizkala; Jean L Rouleau; Victor C Shi; Scott D Solomon; Karl Swedberg; Michael R Zile
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

Review 10.  Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.

Authors:  Sarah Mangiafico; Lisa C Costello-Boerrigter; Ingrid A Andersen; Alessandro Cataliotti; John C Burnett
Journal:  Eur Heart J       Date:  2012-08-31       Impact factor: 29.983
View more
  5 in total

1.  Corin Missense Variants, Blood Pressure, and Hypertension in 11 322 Black Individuals: Insights From REGARDS and the Jackson Heart Study.

Authors:  Vibhu Parcha; Marguerite R Irvin; Leslie A Lange; Nicole D Armstrong; Akhil Pampana; Mariah Meyer; Suzanne E Judd; Garima Arora; Pankaj Arora
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

2.  Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial.

Authors:  Vibhu Parcha; Nirav Patel; Rajat Kalra; Sarabjeet S Suri; Garima Arora; Thomas J Wang; Pankaj Arora
Journal:  J Am Heart Assoc       Date:  2021-03-23       Impact factor: 6.106

3.  Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals.

Authors:  Vibhu Parcha; Nirav Patel; Orlando M Gutierrez; Peng Li; Karen L Gamble; Kiran Musunuru; Kenneth B Margulies; Thomas P Cappola; Thomas J Wang; Garima Arora; Pankaj Arora
Journal:  J Am Coll Cardiol       Date:  2021-05-11       Impact factor: 27.203

4.  The relationship between body mass index and N-terminal pro-B-type natriuretic peptide in community-acquired pneumonia.

Authors:  Jong Seok Lee; Seok Hoon Ko; Jungyoup Lee; Ki Young Jeong
Journal:  Eur J Clin Nutr       Date:  2020-12-14       Impact factor: 4.884

5.  Blockade of β-adrenergic signaling suppresses inflammasome and alleviates cardiac fibrosis.

Authors:  Shipeng Dang; Zhen-Ye Zhang; Ku-Lin Li; Jie Zheng; Ling-Ling Qian; Xiao-Yu Liu; Ying Wu; Chang-Ying Zhang; Xiao-Xi Zhao; Zhi-Ming Yu; Ru-Xing Wang; Tingbo Jiang
Journal:  Ann Transl Med       Date:  2020-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.